Dandan Su

930 total citations
21 papers, 655 citations indexed

About

Dandan Su is a scholar working on Molecular Biology, Immunology and Rehabilitation. According to data from OpenAlex, Dandan Su has authored 21 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Immunology and 3 papers in Rehabilitation. Recurrent topics in Dandan Su's work include Extracellular vesicles in disease (9 papers), Immunotherapy and Immune Responses (6 papers) and Wound Healing and Treatments (3 papers). Dandan Su is often cited by papers focused on Extracellular vesicles in disease (9 papers), Immunotherapy and Immune Responses (6 papers) and Wound Healing and Treatments (3 papers). Dandan Su collaborates with scholars based in China, Finland and Hong Kong. Dandan Su's co-authors include Fang Cheng, Hongbo Chen, Zhanxue Xu, Xiaoju Wang, Zhilian Yue, Paul J. Molino, Stefan Willför, Chunlin Xu, Binbin Zhang and Wenyang Xu and has published in prestigious journals such as ACS Nano, Biomaterials and ACS Applied Materials & Interfaces.

In The Last Decade

Dandan Su

20 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dandan Su China 11 284 203 148 128 112 21 655
Xiaoyu Han China 13 160 0.6× 382 1.9× 176 1.2× 34 0.3× 62 0.6× 35 724
Balaji Bandyopadhyay United States 8 288 1.0× 113 0.6× 58 0.4× 58 0.5× 168 1.5× 9 589
Xichao Zhou China 14 317 1.1× 345 1.7× 170 1.1× 117 0.9× 42 0.4× 23 959
Xiaolei Ding China 14 328 1.2× 138 0.7× 86 0.6× 127 1.0× 129 1.2× 26 770
Zhi Peng China 7 170 0.6× 312 1.5× 148 1.0× 22 0.2× 74 0.7× 12 700
Xiaoyan Xie China 16 405 1.4× 147 0.7× 132 0.9× 54 0.4× 95 0.8× 33 793
Yikun Ju China 13 307 1.1× 240 1.2× 248 1.7× 38 0.3× 190 1.7× 26 780
Fengjin Zhou China 20 401 1.4× 455 2.2× 172 1.2× 53 0.4× 29 0.3× 32 1.0k
A.L. Torres Portugal 11 134 0.5× 269 1.3× 164 1.1× 181 1.4× 39 0.3× 13 654
Yufan Zhu China 12 185 0.7× 376 1.9× 135 0.9× 29 0.2× 61 0.5× 21 712

Countries citing papers authored by Dandan Su

Since Specialization
Citations

This map shows the geographic impact of Dandan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Su more than expected).

Fields of papers citing papers by Dandan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dandan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Su. The network helps show where Dandan Su may publish in the future.

Co-authorship network of co-authors of Dandan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Dandan Su. A scholar is included among the top collaborators of Dandan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dandan Su. Dandan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Zhanxue, Dandan Su, Huixing Wu, et al.. (2025). PD-L1 antibody-modified plant-derived nanovesicles carrying a STING agonist for the combinational immunotherapy of melanoma. Biomaterials. 322. 123396–123396. 4 indexed citations
3.
Su, Dandan, Zhanxue Xu, Yaming Jiu, et al.. (2024). Gut commensal bacteria Parabacteroides goldsteinii-derived outer membrane vesicles suppress skin inflammation in psoriasis. Journal of Controlled Release. 377. 127–145. 22 indexed citations
4.
Liu, Yuanyuan, Chenhui Wang, Hongbo Chen, et al.. (2024). Human Umbilical Cord Mesenchymal Stromal Cell-Derived Extracellular Vesicles Induce Fetal Wound Healing Features Revealed by Single-Cell RNA Sequencing. ACS Nano. 18(21). 13696–13713. 14 indexed citations
5.
Zhou, Jinxia, et al.. (2023). Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes. Annals of Clinical and Translational Neurology. 10(8). 1467–1480. 3 indexed citations
6.
Xu, Zhanxue, Qing‐Ling Fu, Chao He, et al.. (2023). Dual‐Targeting Nanovesicles Carrying CSF1/CD47 Identified from Single‐Cell Transcriptomics of Innate Immune Cells in Heart Transplant for Alleviating Acute Rejection. Advanced Healthcare Materials. 13(7). e2302443–e2302443. 4 indexed citations
7.
Jia, Bo, Dandan Su, Zhanxue Xu, et al.. (2023). Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders. Journal of Extracellular Vesicles. 12(10). e12361–e12361. 71 indexed citations
8.
Liu, Yuanyuan, Hongbo Chen, Dandan Su, et al.. (2023). Human umbilical cord mesenchymal stem cell-derived exosomes promote murine skin wound healing by neutrophil and macrophage modulations revealed by single-cell RNA sequencing. Frontiers in Immunology. 14. 1142088–1142088. 28 indexed citations
9.
Wang, Bo, et al.. (2023). The critical roles of STING in mitochondrial homeostasis. Biochemical Pharmacology. 220. 115938–115938. 7 indexed citations
10.
He, Chao, Manqi Zhang, Lingling Liu, et al.. (2022). Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF. Acta Biomaterialia. 143. 406–417. 10 indexed citations
11.
Zhang, Wei‐xian, et al.. (2022). Small Extracellular Vesicles Derived From MSCs Have Immunomodulatory Effects to Enhance Delivery of ASO-210 for Psoriasis Treatment. Frontiers in Cell and Developmental Biology. 10. 842813–842813. 38 indexed citations
12.
Xu, Zhanxue, et al.. (2022). PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell. Pharmaceutics. 14(6). 1263–1263. 6 indexed citations
13.
Tsai, Hsiang‐i, Yanping Wu, Rui Huang, et al.. (2021). PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia. Acta Pharmaceutica Sinica B. 12(4). 1913–1927. 10 indexed citations
14.
Tsai, Hsiang‐i, Xiaobin Zeng, Longshan Liu, et al.. (2021). NF45/NF90‐mediated rDNA transcription provides a novel target for immunosuppressant development. EMBO Molecular Medicine. 13(3). e12834–e12834. 7 indexed citations
15.
Wang, Hao, et al.. (2021). Cellular nanovesicles with bioorthogonal targeting enhance photodynamic/photothermal therapy in psoriasis. Acta Biomaterialia. 134. 674–685. 31 indexed citations
16.
Xu, Zhanxue, Hsiang‐i Tsai, Yingyi Wu, et al.. (2020). Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation. ACS Nano. 14(7). 7959–7969. 45 indexed citations
17.
Yang, Min, Zhanxue Xu, Hsiang‐i Tsai, et al.. (2020). PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation. Biomaterials Science. 9(4). 1246–1255. 16 indexed citations
18.
Parvanian, Sepideh, Dandan Su, Yaming Jiu, et al.. (2020). Exosomal vimentin from adipocyte progenitors accelerates wound healing. Cytoskeleton. 77(10). 399–413. 27 indexed citations
19.
Xu, Wenyang, Binbin Zhang, Fang Cheng, et al.. (2019). On Low-Concentration Inks Formulated by Nanocellulose Assisted with Gelatin Methacrylate (GelMA) for 3D Printing toward Wound Healing Application. ACS Applied Materials & Interfaces. 11(9). 8838–8848. 208 indexed citations
20.
Su, Dandan, Hsiang‐i Tsai, Zhanxue Xu, et al.. (2019). Exosomal PD‐L1 functions as an immunosuppressant to promote wound healing. Journal of Extracellular Vesicles. 9(1). 1709262–1709262. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyu Han Breakdown of academic impact, for papers by Balaji Bandyopadhyay Breakdown of academic impact, for papers by Xichao Zhou Breakdown of academic impact, for papers by Xiaolei Ding Breakdown of academic impact, for papers by Zhi Peng Breakdown of academic impact, for papers by Xiaoyan Xie Breakdown of academic impact, for papers by Yikun Ju Breakdown of academic impact, for papers by Fengjin Zhou Breakdown of academic impact, for papers by A.L. Torres Breakdown of academic impact, for papers by Yufan Zhu
Rankless by CCL
2026